Exchange Capital Management’s Celgene Corp CELG Stock Holding History

Exchange Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-200	Closed	-$18K	–	304
2018 Q3	$18K	Hold	200	–	–	0.01%	207
2018 Q2	$16K	Hold	200	–	–	﹤0.01%	201
2018 Q1	$18K	Hold	200	–	–	0.01%	178
2017 Q4	$21K	Hold	200	–	–	0.01%	171
2017 Q3	$29K	Hold	200	–	–	0.01%	165
2017 Q2	$26K	Hold	200	–	–	0.01%	153
2017 Q1	$25K	Hold	200	–	–	0.01%	140
2016 Q4	$23K	Hold	200	–	–	0.01%	123
2016 Q3	$21K	Hold	200	–	–	0.01%	139
2016 Q2	$20K	Buy	+200	New	+$20.7K	0.01%	130
2015 Q1	–	Sell	-200	Closed	-$22K	–	368
2014 Q4	$22K	Hold	200	–	–	0.01%	136
2014 Q3	$19K	Hold	200	–	–	0.01%	134
2014 Q2	$17K	Hold	200	–	–	0.01%	143
2014 Q1	$14K	Hold	200	–	–	0.01%	166
2013 Q4	$17K	Hold	200	–	–	0.01%	125
2013 Q3	$15K	Hold	200	–	–	0.01%	122
2013 Q2	$12K	Buy	+200	New	+$12K	0.01%	125

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Exchange Capital Management's CELG Position: Q4 2018 in Review

Exchange Capital Management sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 200 shares — an estimated $18K sold.

Exchange Capital Management first reported a position in CELG in Q2 2013 and held it in 17 quarters. The position peaked at $29K in Q3 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

Exchange Capital Management reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
Exchange Capital Management sold 200 Celgene Corp shares in Q4 2018, an estimated $18K.
Exchange Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 17 quarters.
Exchange Capital Management's Celgene Corp position peaked at $29K in Q3 2017.
1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Exchange Capital Management's 13F filing for Q4 2018, filed 1 Feb 2019.